Genmab A/S/ DK0010272202 /
| 11/30/2023 12:00:00 AM | Chg. +19.00 | Volume | Bid5:10:00 PM | Ask5:10:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2,161.00DKK | +0.89% | 266,388 Turnover: 560.94 mill. |
2,154.00Bid Size: - | 2,156.00Ask Size: - | 141.82 bill.DKK | - | 46.91 |
GlobeNewswire
3/15/2022
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of the...
GlobeNewswire
3/8/2022
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and ...
pressetext
2/21/2022
PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell recepto...
GlobeNewswire
2/21/2022
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Again...
GlobeNewswire
2/16/2022
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production...
GlobeNewswire
2/15/2022
BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide...
GlobeNewswire
2/1/2022
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Va...
GlobeNewswire
1/25/2022
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Yea...
GlobeNewswire
1/11/2022
BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential Hi...
GlobeNewswire
1/10/2022
BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision I...
GlobeNewswire
1/5/2022
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vac...
GlobeNewswire
12/9/2021
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Ind...
GlobeNewswire
12/8/2021
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
GlobeNewswire
11/25/2021
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of ...
GlobeNewswire
11/22/2021
Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Effica...
GlobeNewswire
11/19/2021
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booste...
GlobeNewswire
11/19/2021
BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma